Basics Arvinas, Inc. IPO Date: September 24, 2018 Sector: Healthcare Industry: Biotech Market Cap: $540.14M Activated in VL: True Average Daily Range Avg Daily Range: $1.09 | 2.96% Avg Daily Range (30 D): $0.16 | 2.08% Avg Daily Range (90 D): $0.22 | 3.01% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): 1.59M Avg Daily Volume (90 D): 2.15M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 103 Avg Trade Size (Sh.) (90 D): 101 Institutional Trades Total Inst.Trades: 3,014 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $2.03M Avg Inst. Trade (90 D): $1.78M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.64M Avg Closing Trade (30 D): $2.01M Avg Closing Trade (90 D): $2.02M Avg Closing Volume: 80.17K     News Jun 13, 2025 @ 11:00 AM Arvinas Presents Preclinical Data for PROTAC BCL6 ... Source: N/A Jun 6, 2025 @ 11:00 AM Arvinas Announces Submission of New Drug Applicati... Source: N/A May 6, 2025 @ 10:00 PM Kirby McInerney LLP Announces Investigation of Cla... Source: N/A Apr 30, 2025 @ 5:00 PM Metastatic HR+/HER2- Breast Cancer Market—T... Source: Delveinsight Apr 4, 2025 @ 11:00 AM Arvinas Presents First-in-Human Data for Investiga... Source: N/A Financials   TTM Q1 2025 Q3 2024 Basic EPS $1.14 $-.68 Diluted EPS $1.14 $-.68 Revenue $ $ 188.8M $ 102.4M Gross Profit $ $ $ Net Income / Loss $ $ 82.9M $ -49.2M Operating Income / Loss $ $ 71.4M $ -60.3M Cost of Revenue $ $ $ Net Cash Flow $ $ -19.5M $ -75.1M PE Ratio